Study Title | ALTE15N2: LEAHRN (Late Effects After High-Risk Neuroblastoma) Study |
---|---|
Protocol ID | ALTE15N2 |
Disease (Sub Disease) | Recurrent Neuroblastoma |
Diagnosis Stage | Relapse/refractory |
Location | WA / NZ |
Sponsor | Children's Oncology Group |
Collaborators | National Cancer Institute (NCI) |
Links | https://clinicaltrials.gov/ct2/show/NCT03057626 |
Trial Status | Open |
Trial Open Date | 05/06/2017 |
Sites | Perth Children's Hospital / Starship Hospital |
Study Type | Late Effects |
Phase | Not applicable |
Age Eligibility | 5 Years to 50 Years |
International registry ID's | NCT03057626 |